A new asthma treatment, depemokimab, has shown promise in reducing exacerbations while maintaining a strong safety profile, according to findings presented at the 2025 American Academy of Allergy, ...
Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback